Craft

Bruker Cellular Analysis

Revenue

$78.6 M

FY, 2022

Bruker Cellular Analysis Summary

Company Summary

Overview
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. It makes antibody screening tools for pharmaceutical and biotech organizations. The company develops a platform and software suite that delivers cell processing with information about cell function. Berkeley Lights also provides an opto cell therapy development workflow that allows users to link single-cell phenotype and function to gene expression.
Type
Subsidiary
Status
Active
Founded
2011
HQ
Emeryville, CA, US | view all locations
Website
https://brukercellularanalysis.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Keith Breinlinger

    Keith Breinlinger, Chief Technology Officer

  • Mimi Healy

    Mimi Healy, Chief Products Officer

  • Lucas S. Vitale

    Lucas S. Vitale, Chief Human Resources Officer

  • Mark Lasinski

    Mark Lasinski, SVP, Global Sales

Operating MetricsView all

Customers

80
27.0%

FY, 2021

New Customers

22

FY, 2020

Trademark Applications (US)

5
54.5%

FY, 2021

LocationsView all

2 locations detected

  • Emeryville, CA HQ

    United States

    5858 Horton St #320

  • Shang Hai Shi

    China

    Zhang Heng Lu, Pu Dong Xin Qu

Bruker Cellular Analysis Financials

Summary Financials

Revenue (Q2, 2023)
$14.1M
Gross profit (Q2, 2023)
$6.0M
Net income (Q2, 2023)
($50.2M)
Cash (Q2, 2023)
$31.0M
EBIT (Q2, 2023)
($47.2M)

Footer menu